Trial finds therapeutics including remdesivir have "little or no" effect on COVID-19 patients: WHO


By Liu Qu

GENEVA, Oct. 16 (Xinhua) -- Latest results from an international trial coordinated by the World Health Organization (WHO) on four COVID-19 therapeutic drugs indicated that they have "little or no" effect in preventing death from COVID-19 or reducing time in hospital, the WHO said on Friday.

WHO discontinued the hydroxychloroquine arm of the trial in June and the combination of lopinavir and ritonavir in July, citing that the two therapeutics had brought little reduction in the mortality of hospitalized COVID-19 patients.

"Interim results from the trial now show that the other two drugs in the trial, remdesivir and interferon, have little or no effect in preventing death from COVID-19 or reducing time in hospital," said WHO Director-General Tedros Adhanom Ghebreyesus at a press briefing on Friday.

The results were from the Solidarity Therapeutics Trial, overseen by the WHO.

According to Tedros, the Solidarity Trial is still recruiting about 2,000 patients every month and will assess other treatments, including monoclonal antibodies and new antivirals.

"For the moment, the corticosteroid dexamethasone is still the only therapeutic shown to be effective against COVID-19, for patients with severe disease," Tedros said, adding that full results of the trial are expected to be published shortly in a leading scientific journal.

The Solidarity Trial, launched in March, is the world's largest randomized controlled trial of COVID-19 therapeutics, involving almost 13,000 patients in 500 hospitals in 30 countries, according to the WHO.

As the world is in struggling to contain the COVID-19 pandemic, countries including France, Italy, China, Russia, Britain and the United States are racing to find a vaccine.

According to the website of the WHO, as of Oct. 15, there were 198 COVID-19 candidate vaccines being developed worldwide, and 42 of them were in clinical trials.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

Next In World

Japan ruling party calls for major green investment in draft plan
Saudi-led coalition says destroyed two mines laid by Yemen's Houthis in Red Sea - Saudi state TV
Exclusive: Suspected North Korean hackers targeted COVID vaccine maker AstraZeneca - sources
Thousands attend funeral of Sudan's last democratically elected PM
Japan's Suga vows stimulus package focusing on green, digital innovation
Thai protesters target would-be coup makers as rumours swirl
Analysis: Covert Israeli-Saudi meeting sends Biden a strong message on Iran
Saudi-led coalition carries out air raids on Houthi barracks in Sanaa area - residents
Five COVID-19 patients killed in Indian hospital fire
New Delhi ambulance group grapples with surging COVID-19 quarantine deaths

Stories You'll Enjoy